Head to Head Comparison: Integrated BioPharma (OTCMKTS:INBP) versus Eliem Therapeutics (NASDAQ:ELYM)
Insider & Institutional Ownership 25.3% of Integrated BioPharma shares are held by institutional investors. Comparatively, 69.8% of Eliem Therapeutics shares are held by institutional investors. 67.2% of Integrated BioPharma shares are held by insiders. Comparatively, 4.7% of Eliem Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money […]
Insider & Institutional Ownership 25.3% of Integrated BioPharma shares are held by institutional investors. Comparatively, 69.8% of Eliem Therapeutics shares are held by institutional investors. 67.2% of Integrated BioPharma shares are held by insiders. Comparatively, 4.7% of Eliem Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money […]
